Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-12-17
1991-09-10
Stone, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514807, A61K 3734
Patent
active
050473980
ABSTRACT:
There is disclosed, in one aspect, an antidiuretic composition in oral dosage form for humans. This composition comprises an antidiuretically effective amount of 1-deamino-8-D-arginine vasopressin (DDAVP) and a pharmaceutically acceptable carrier. The composition is capable of dissolving and being absorbed in the gastrointestinal tract of a human. The composition isused in tablet, capsule, or other generally accepted oral dosage form and generally from about 50 to about 200 micrograms of DDAVP is used per unit dosage In another aspect, there is disclosed a method for treating diabetes insipidus. This method comprises orally administering an antidiuretically effective amount of DDAVP to a human. The DDAVP is substantially dissolved and absorbed in the gastrointestinal tract of the person so treated.
REFERENCES:
patent: 3454549 (1969-07-01), Boissonnas
patent: 3497491 (1970-02-01), Zaoral
Kinter et al, cited in Chem. Abstracts, vol. 97:193479x 1982.
American Heritage Dictionary 2nd ed p. 924.
Remingtons Pharm. Sciences 15th Ed. (1975) pp. 83 & 84.
Hagstam Helmer
Vilhardt Hans
Ferring B.V.
Stone Jacqueline
LandOfFree
DDAVP antidiuretic and method therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DDAVP antidiuretic and method therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DDAVP antidiuretic and method therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-540149